A record rent is about to be set in Cambridge’s labs market, as investors, developers and local authorities struggle to keep pace with demand from life sciences occupiers.
Germany’s BioNTech signed a deal with the
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
